← All indications
Syncope
A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)
Subtype terms (1)
More specific conditions that are subtypes of Syncope in the MeSH hierarchy.
- Syncope, Vasovagal
11 drugs (10 approved, 1 experimental)
Drugs by status
Approved for this indication (1)
Phase 3 trials (5)
Phase 2 trials (5)
Other trials (6)
Organizations
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (14)
- Shahid Beheshti University of Medical Sciences
- Mahidol University
- Thomas Jefferson University
- University of Tehran
- Urmia University of Medical Sciences
- Valley Health System
- Ahvaz Jundishapur University of Medical Sciences
- Imam Khomeini Hospital
- Isfahan University
- Medtronic
- Rowan University
- Rajaie Cardiovascular Medical and Research Center
- AJA University of Medical Sciences
- Tehran University of Medical Science
Organization Involved with Phase 2 Indications (4)
Organization Involved with Other Experimental Indications (5)